Dietrich; Evelyne

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dietrich; Evelyne.The latest application filed is for "mannose derivatives for treating bacterial infections".

Company Profile

5.14.14

Dietrich; Evelyne - Laval CA
Dietrich; Evelyne - St. Laurent CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Mannose Derivatives for Treating Bacterial Infections App 20220135609 - Ramtohul; Yeeman K. ; et al.	2022-05-05
2,7-dibromospiro[fluorene-9,4'-piperidine] compounds Grant 10,913,761 - Ramtohul , et al. February 9, 2	2021-02-09
Mannose Derivatives for Treating Bacterial Infections App 20200270293 - Ramtohul; Yeeman K. ; et al.	2020-08-27
Mannose derivatives for treating bacterial infections Grant 10,669,298 - Ramtohul , et al.	2020-06-02
Mannose derivatives for treating bacterial infections Grant 10,407,414 - Gallant , et al. Sept	2019-09-10
Mannose Derivatives for Treating Bacterial Infections App 20190106450 - Ramtohul; Yeeman K. ; et al.	2019-04-11
Mannose Derivatives for Treating Bacterial Infections App 20180244658 - Gallant; Michel ; et al.	2018-08-30
Mannose derivatives for treating bacterial infections Grant 9,963,478 - Ramtohul , et al. May 8, 2	2018-05-08
Bicyclic Heteroaryl Compounds Useful As Inhibitors Of The Par-2 Signaling Pathway App 20180057505 - SAYEGH; Camil Elie ; et al.	2018-03-01
Mannose derivatives for treating bacterial infections Grant 9,890,176 - Dietrich , et al. February 13, 2	2018-02-13
Mannose derivatives for treating bacterial infections Grant 9,598,454 - Ramtohul , et al. March 21, 2	2017-03-21
Mannose Derivatives for Treating Bacterial Infections App 20160235775 - Ramtohul; Yeeman K. ; et al.	2016-08-18
Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections Grant 8,946,144 - Tanaka , et al. February 3, 2	2015-02-03
Glycopeptide and lipoglycopeptide antibiotics with improved solubility Grant 8,901,072 - Rafai Far , et al. December 2, 2	2014-12-02
Mannose Derivatives For Treating Bacterial Infections App 20140274930 - Dietrich; Evelyne ; et al.	2014-09-18
Mannose Derivatives For Treating Bacterial Infections App 20140243283 - Ramtohul; Yeeman K. ; et al.	2014-08-28
Mannose Derivatives For Treating Bacterial Infections App 20130261077 - Bennani; Youssef Laafiret ; et al.	2013-10-03
Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections Grant 8,524,691 - Dietrich , et al. September 3, 2	2013-09-03
Phosphonated Rifamycins and uses thereof for the prevention and treatment of bone and joint infections Grant 8,404,664 - Rose , et al. March 26, 2	2013-03-26
Glycopeptide And Lipoglycopeptide Antibiotics With Improved Solubility App 20120149632 - Rafai Far; Adel ; et al.	2012-06-14
Phosphonated Rifamycins And Uses Thereof For The Prevention And Treatment Of Bone And Joint Infections App 20110263534 - Rose; Yannick Stephane ; et al.	2011-10-27
Phosphonated Rifamycins And Uses Thereof For The Prevention And Treatment Of Bone And Joint Infections App 20110178001 - Dietrich; Evelyne ; et al.	2011-07-21
Phosphonated Glycopeptide And Lipoglycopeptide Antibiotics And Uses Thereof For The Prevention And Treatment Of Bone And Joint Infections App 20100113333 - Tanaka; Kelly ; et al.	2010-05-06
Phosphonated Fluoroquinolones, Antibacterial Analogs Thereof, and Methods for the Prevention and Treatment of Bone and Joint Infections App 20080287396 - Delorme; Daniel ; et al.	2008-11-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.